Clone | Receptor Binding | Adenylyl Cyclase Inhibition | Ca2+ Channel Inhibition | |||
---|---|---|---|---|---|---|
Bmax | DPDPEKi | IC50 | Imax | IC50 | Imax | |
pmol/mg | nM | % | nM | % | ||
GH3DOR | 0.55 ± .071-a | 5.8 ± 1.13 | 2.2 ± 0.8 | 37 ± 2.0 | No inhibition | No inhibition |
GH3MORDOR | 2.45 ± .631-b | 1.77 ± 0.60 | 1.1 ± 0.021-c | 78 ± 0.41-c | 1.61-d | 21 ± 1.31-d |
Receptor density (Bmax) values were determined from Scatchard analysis of saturation binding of [3H]diprenorphine (GH3DOR) or [3H]DPDPE (GH3MORDOR). Affinity (Ki) values were determined from competition binding experiments using the same radiolabeled ligands with increasing concentrations of DPDPE (0.01 nM to 10 μM) as described underExperimental Procedures. IC50 and maximal inhibition (Imax) values for δ-opioid receptor inhibition of adenylyl cyclase activity and Ca2+ currents by DPDPE were determined as described under Experimental Procedures. For receptor binding and adenylyl cyclase experiments, data represent the mean ± S.E.M. of a minimum of three separate experiments each performed in triplicate. For electrophysiological experiments, data represent the mean ± S.E.M. of measurements obtained from a minimum of four cells.